Valeant in talks to sell Salix stomach-drug unit in $10 billion deal – Reuters
Reuters |
Valeant in talks to sell Salix stomach-drug unit in $10 billion deal
Reuters A sign for the headquarters of Valeant Pharmaceuticals International Inc is seen in Laval, Quebec June 14, 2016. REUTERS/Christinne Muschi. By Carl O'Donnell and Svea Herbst-Bayliss. Canada's Valeant Pharmaceuticals International Inc (VRX.TO) said … Valeant may sell a family jewel to survive, and the stock is soaringBusiness Insider Valeant shares spike more than 30% as it considers selling Salix unitCNBC Valeant shares jump more than 30% on divestiture talksMarketWatch Barron’s (blog) –Motley Fool –Investor’s Business Daily –StreetInsider.com all 162 news articles » |